ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > NY-ESO-1

NY-ESO-1

概要

Name:Cancer/testis antigen 1
Target Synonym:CTAG1A more,Autoimmunogenic cancer/testis antigen NY-ESO-1,LAGE2A,CTAG1,CTAG1A,CTAG1B,Cancer/Testis Antigen 1B,Cancer/Testis Antigen 6.1,L Antigen Family Member 2,Cancer/Testis Antigen 1,LAGE-2,LAGE2B,CT6.1,CTAG,ESO1,Cancer Antigen 3,NY-ESO-1,LAGE2,New York Esophageal Squamous Cell Carcinoma 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:16
Lastest Research Phase:Phase 2 Clinical

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
タグ別:
製造番号 種類 製品説明 構造 純度 特徴
CHEK-STP114 Human NY-ESO-1 specific TCR-HEK293 cell line
ACRO Quality

生物活性データの一部

CHEK-STP114-Cell-based assay
 NY-ESO-1 FACS

FACS analysis NY-ESO-1 specific TCR on NY-ESO-1 specific TCR-HEK293 cell line.
FACS assay shows that PE-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Tetramer Protein can bind to NY-ESO-1 specific TCR-HEK293 cell line. NY-ESO-1 specific TCR-HEK293 cell line was red line, Negative control HEK293 cells was grey line (QC tested).

Synonym Name

NY-ESO-1

Background

Clinical and Translational Updates

This web search service is supported by Google Inc.

totopphone